when does the semaglutide patent expire Indian pharma launches low-cost Ozempic generics as expires Semaglutide's patent expires today. What

Avexitide, which has been granted FDA breakthrough therapy designation, has shown significant effectiveness in treating Postbariatric Hypoglycemia (PBH) and congenital hyperinsulinism, and is expected to commence Phase 3 trials for PBH by early 2025

FDA has the ability to restrict the use of 503A compounding from bulk if it has safety concerns

Energy support

SGLT2 inhibitors, a different class of diabetes medications, are associated with an increased incidence of yeast infections

To move beyond correlation toward causality, large-scale, longitudinal, and mechanistic studies integrating multi-omics approaches including metagenomics, metabolomics, transcriptomics, and immunophenotyping are needed